Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamatergic receptors, also known as glutamate receptors, are a family of cell surface proteins that mediate the effects of the neurotransmitter glutamate—the primary excitatory neurotransmitter in the central nervous system (CNS). These receptors are essential for fast excitatory synaptic transmission, synaptic plasticity, neuronal development, learning, memory formation, and overall neuronal communication. They are divided into two main classes: Ionotropic (NMDA, AMPA, Kainate) which are ligand-gated ion channels, and Metabotropic (mGluR1–mGluR8) which are G-protein-coupled receptors.
Ligand binding leading to ion channel opening (ionotropic) or G-protein activation (metabotropic)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamatergic Receptor.